The Medacta International GMK Sphere Post-Marketing Surveillance Study
Sponsor: Medacta International SA
This NA trial investigates Arthritis and Avascular Necrosis and is currently ongoing. Medacta International SA leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jan 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Nov 2022 — Jan 2024 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2020 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medacta International SA
For direct contact, visit the study record on ClinicalTrials.gov .